Clinical impact of Fc gamma RIIa/Fc gamma RIIIa polymorphism receptors and KRAS mutations in metastatic colorectal cancers treated by cetuximab and irinotecan
Journal article published in 2008 by
F. Bibeau,
E. Crapez,
F. Di Fiore,
S. Thezenas,
M. Ychou,
A. Lamy,
F. Blanchard,
T. Frebourg,
P. Michel,
J.-C. Sabourin,
F. Boissiere-Michot 
